IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q3 2019 Holdings

Filed 2019-11-14 | 3 holdings | $2.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MMA Capital Holdings Inc(MMAC)COM55315D105$2.2K72,55280.4%
Onconova Therapeutics IncCOM NEW68232V405$524616,38919.3%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$8390,6240.3%